FLT3 and acute myeloid leukemia: To explore gene repression that sensitized AML to FLT3 inhibitors, an shRNA genome-wide library screen was performed in an FLT3-mutant AML cell line (Molm13) treated with the FLT3 inhibitor CEP-701 [33].